Base Therapeutics’ NK510 Receives US FDA Clearance for Advanced Solid Tumor Studies
Shanghai-based cell therapy specialist Base Therapeutics has achieved clearance from the US Food and Drug...
Base Therapeutics
Base Therapeutics Secures Series A1 Funding to Advance Gene Editing Pipelines
Base Therapeutics, a Guangdong-based firm specializing in base editing and prime editing technologies, has reportedly...